Wearable electrocardiogram devices in patients with congenital long QT syndrome: The SMART-QT study
Archives of Cardiovascular Diseases · 2024-05 · 117 (5) · 313-320
DOI: 10.1016/j.acvd.2024.02.010 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Archives of Cardiovascular Diseases, 2024-05. Verfasst von Antoine Delinière und 13 weiteren Autor:innen. Beteiligte Einrichtung: National Reference Centre for Inherited Arrhythmia of Lyon (CERA), Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, 69500 Bron, France; E…. Hauptthemen laut MEDLINE: Long QT Syndrome, Heart Rate, Wearable Electronic Devices, Predictive Value of Tests. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Agence Nationale de la Recherche, Université de Bordeaux.
Abstract (Originalsprache)
BACKGROUND: In patients with congenital long QT syndrome (LQTS), the risk of ventricular arrhythmia is correlated with the duration of the corrected QT interval and the changes in the ST-T wave pattern on the 12-lead surface electrocardiogram (12L-ECG). Remote monitoring of these variables could be useful. AIM: To evaluate the abilities of two wearable electrocardiogram devices (Apple Watch and KardiaMobile 6L) to provide reliable electrocardiograms in terms of corrected QT interval and ST-T wave patterns in patients with LQTS. METHODS: In a prospective multicentre study (ClinicalTrials.gov identifier: NCT04728100), a 12L-ECG, a 6-lead KardiaMobile 6L electrocardiogram and two single-lead Apple Watch electrocardiograms were recorded in patients with LQTS. The corrected QT interval and ST-T wave patterns were evaluated manually. RESULTS: Overall, 98 patients with LQTS were included; 12.2% were children and 92.8% had a pathogenic variant in an LQTS gene. The main genotypes were LQTS type 1 (40.8%), LQTS type 2 (36.7%) and LQTS type 3 (7.1%); rarer genotypes were also represented. When comparing the ST-T wave patterns obtained with the 12L-ECG, the level of agreement was moderate with the Apple Watch (k=0.593) and substantial with the KardiaMobile 6L (k=0.651). Regarding the corrected QT interval, the correlation with 12L-ECG was strong for the Apple Watch (r=0.703 in lead II) and moderate for the KardiaMobile 6L (r=0.593). There was a slight overestimation of corrected QT interval with the Apple Watch and a subtle underestimation with the KardiaMobile 6L. CONCLUSIONS: In patients with LQTS, the corrected QT interval and ST-T wave patterns obtained with the Apple Watch and the KardiaMobile 6L correlated with the 12L-ECG. Although wearable electrocardiogram devices cannot replace the 12L-ECG for the follow-up of these patients, they could be interesting additional monitoring tools.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Reference Centre for Inherited Arrhythmia of Lyon (CERA), Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, 69500 Bron, France; Electrophysiology Unit, Hôpital Cardiologique Louis Pradel, Hospices Ci…
- Electrophysiology Unit, Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, 69500 Bron, France; Paediatric and Congenital Heart Disease Medico-Surgical Unit, Hôpital Cardiologique Louis Pradel, Hospices Civils…
- Service de Cardiologie, Centre de Compétence des Troubles du Rythme Cardiaque d'Origine Héréditaire, Hôpital Arnaud-de-Villeneuve, CHU de Montpellier, 34295 Montpellier, France.
- Service de Cardiologie, Centre de Compétence des Troubles du Rythme Cardiaque d'Origine Héréditaire, Hôpital Arnaud-de-Villeneuve, CHU de Montpellier, 34295 Montpellier, France; CNRS UMR9214, Inserm U1046, PHYMEDEXP, Un…
- Electrophysiology Unit, Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, 69500 Bron, France.
- National Reference Centre for Inherited Arrhythmia of Lyon (CERA), Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, 69500 Bron, France.
Förderung
- Agence Nationale de la Recherche
- Université de Bordeaux
Zitieren
APA
Delinière, A., Bessière, F., Placide, L., Pasquié, J. L., Haddad, C., Tirel, S., Mokhtar, H., Morel, E., Gardey, K., Dulac, A., Ditac, G., Sacher, F., Denjoy, I., & Chevalier, P. (2024). Wearable electrocardiogram devices in patients with congenital long QT syndrome: The SMART-QT study. Archives of Cardiovascular Diseases, 117(5), 313-320. https://doi.org/10.1016/j.acvd.2024.02.010
Vancouver
Delinière A, Bessière F, Placide L, Pasquié JL, Haddad C, Tirel S, et al. Wearable electrocardiogram devices in patients with congenital long QT syndrome: The SMART-QT study. Archives of Cardiovascular Diseases. 2024;117(5):313-320. doi:10.1016/j.acvd.2024.02.010
BibTeX
@article{Delinire2024,
author = {Delinière, Antoine and Bessière, Francis and Placide, Leslie and Pasquié, Jean-Luc and Haddad, Christelle and Tirel, Solenn and Mokhtar, Hajira and Morel, Elodie and Gardey, Kevin and Dulac, Arnaud and Ditac, Geoffroy and Sacher, Frédéric and Denjoy, Isabelle and Chevalier, Philippe},
title = {Wearable electrocardiogram devices in patients with congenital long QT syndrome: The SMART-QT study},
journal = {Archives of Cardiovascular Diseases},
year = {2024},
volume = {117},
number = {5},
pages = {313--320},
doi = {10.1016/j.acvd.2024.02.010}
}
EUVIMED